Cargando…
Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease
BACKGROUND: Fabry disease (FD) is an X-linked recessive hereditary lysosomal storage disorder which results in the accumulation of globotriaosylceramid (Gb3) in tissues of kidney and heart as well as central and peripheral nervous system. Besides prominent renal and cardiac organ involvement, cochle...
Autores principales: | Köping, Maria, Shehata-Dieler, Wafaa, Cebulla, Mario, Rak, Kristen, Oder, Daniel, Müntze, Jonas, Nordbeck, Peter, Wanner, Christoph, Hagen, Rudolf, Schraven, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697846/ https://www.ncbi.nlm.nih.gov/pubmed/29161295 http://dx.doi.org/10.1371/journal.pone.0188103 |
Ejemplares similares
-
Characterization of vertigo and hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2018) -
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018) -
Hot topics in Fabry disease
por: Cairns, Tereza, et al.
Publicado: (2018) -
Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018) -
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
por: Müntze, Jonas, et al.
Publicado: (2019)